BioSphere Medical Names Michael Miley Senior Director for Worldwide Market Development.Business Editors/Health Writers ROCKLAND, Mass.--(BW HealthWire)--Jan. 10, 2001 Former Boston Scientific executive to develop global business strategies for growing embolization embolization /em·bo·li·za·tion/ (em?bo-li-za´shun) 1. the process or condition of becoming an embolus. 2. therapeutic introduction of a substance into a vessel in order to occlude it. markets BioSphere Medical, Inc. (Nasdaq:BSMD), a medical device company that is pioneering the use of bioengineered microspheres to treat hypervascularized tumors and vascular malformations by occluding their blood supply, today announced that Michael Miley (38) has been named to the new position of Senior Director for Worldwide Market Development. Miley's key responsibilities are to define and implement strategic market development programs and identify business development opportunities to expand the company's line of embolotherapy products. He will focus initially on pursuit of opportunities for BioSphere Medical in growing liver and tumor embolization markets worldwide. "Mike's years of experience in global sales and marketing management in the medical device field make him an ideal candidate to manage BioSphere Medical's worldwide business development program," said John Carnuccio, BioSphere Medical's president and chief executive officer. "Mike brings a high level of enthusiasm and a proven ability to design and execute successful medical device market and product development strategy. His leadership will be an important asset as we seek to expand BioSphere Medical's presence in key growth markets around the world." "I am excited by the opportunity to contribute my expertise, experience and energy to the BioSphere team," said Miley. Miley's previous experience included more than 10 years in a variety of sales and marketing management positions at Boston Scientific. He most recently served as Director of International Marketing (Aneurysmal aneurysmal pertaining to or arising from an aneurysm. aneurysmal bone cyst see bone cyst. Therapies) for the Medi-tech division. Miley earned his Bachelor of Science Noun 1. Bachelor of Science - a bachelor's degree in science BS, SB bachelor's degree, baccalaureate - an academic degree conferred on someone who has successfully completed undergraduate studies Degree in Biology from the University of Tampa The University of Tampa, or UT, is a private, co-educational university in downtown Tampa, Florida. It is accredited by the Southern Association of Colleges and Schools. In 2006, the University celebrated its 75th anniversary. and his Executive MBA MBA abbr. Master of Business Administration Noun 1. MBA - a master's degree in business Master in Business, Master in Business Administration Degree from Boston University. About BioSphere Medical BioSphere Medical, Inc., based in Rockland, Massachusetts, is a medical device company focused on embolotherapy, the treatment of tumors and vascular malformations by occluding their blood supply. The company is pioneering the use of patented and proprietary bioengineered Microspheres as a new class of embolics. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement - This press release contains forward-looking statements that involve risks and uncertainties, including those relating to the appointment of Michael Miley as Senior Director for World Wide Market Development, and the ability of the Company to commercialize its products for an array of applications. Among the important factors that could cause actual events to differ materially from those indicated by forward-looking statements in this release are the failure of the Company to achieve or maintain necessary regulatory approvals, either in the United States or internationally, with respect to the manufacture and sale of its products; to successfully develop and commercialize the Embosphere(R) Microspheres and HepaSphere SAP(TM) Microsphere Not to be confused with Glass microphere. This article largely refers to micropheres or protein protocells as small spherical units postulated by some scientists as a key stage in the origin of life. technologies for uterine artery embolization Uterine artery embolization (UAE) or Uterine Fibroid Embolization (UFE) is a procedure where an interventional radiologist uses a catheter to deliver small particles that block the blood supply to the fibroids. See also
A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 1999, form 10-Q Form 10-Q See 10-Q. for the quarter ended September 30, 2000, and other periodic reports filed by the Company with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion